Pharmaceuticals and Medical Devices Agency

The Pharmaceuticals and Medical Devices Agency (独立行政法人 医薬品医療機器総合機構) is a Japanese governmental organization, similar in function to the Food and Drug Administration (FDA) in the United States or the Medicines and Healthcare products Regulatory Agency in the United Kingdom or the Central Drugs Standard Control Organization (CDSCO) in India[1] or the European Medicines Agency in Europe.

Pharmaceuticals and Medical Devices Agency
Agency overview
FormedApril 1 2004


Among other things, the agency is tasked with the following.

  • Drug and medical device testing:
    • Scientific review of market authorization applications based on Japanese pharmaceutical law
    • Advice in clinical trials or in the preparation of dossiers for the registration procedure (New Drug Applications (NDA))
    • Inspection and conformity assessment of Good Clinical Practice (GCP), Good Laboratory Practice (GLP), and Good Practice Systems and Programs (GPSP)
    • Auditing of manufacturers to ensure they conform to Good Manufacturing Practice (GMP) and have a suitable Quality Management System (QMS)
  • Post-marketing drug safety:
    • The collection, analysis and distribution of data on the quality, efficacy, and safety data of medicines and medical devices
    • Advising consumers on approved products
    • Research on the development of industry standards
  • Victim compensation:
    • Payment of medical costs, lost wages, and pain and suffering for those who suffer injury or disability resulting from the use of medical products
    • Disbursement of funds to those infected with HIV as a result of blood transfusions


  1. Nagasaka, Satoru. "An Overview of Pharmaceutical and Medical Device Regulation in Japan" (PDF). Morgan, Lewis & Bockius LLP. Retrieved 30 September 2012.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.